Development of the predictive model for I stage breast cancer
Open Access
- 18 September 2021
- journal article
- research article
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 17 (2) , 14‑22
Abstract
Objective: development of a predictive model based on binary regression to determine the likelihood of progression of I stage breast cancer.Materials and methods. A retrospective analysis of data of 385 patients with T1N0M0 stage breast cancer was performed. The minimum follow-up period was 120 months and the maximum made 256 months, with an average follow-up of 191 ± 36 months (16 ± 3 years). Using a forward stepwise selection (binary regression), the most important prognostic factors were selected, on the basis of which the predictive model “Risk Assessment Algorithm for Recurrence of Breast Carcinoma” was constructed.Results. During the study period, recurrence of stage I breast cancer was reported in 67 patients, representing 17.4 % of the total cohort. Five prognostic factors were selected by binary regression: grade, histological type, estrogen receptor expression, HER2 / neu overexpression and Ki-67 amplification. Kaplan–Meier analysis and Cox proportional hazards method demonstrated the influence of each of the selected factors on disease-free survival. Comparative analysis with other existing models showed that our prognostic model is inferior to Adjuvant! Online in terms of sensitivity (85 % ver- sus 95 %). However, it is superior in specificity (58 % versus 38 %), PPV (69 % versus 63 %) and AUC (84 % versus 70 %).Conclusions. In I stage breast cancer, factors such as grade, histological type, estrogen receptor expression, HER2 / neu overexpression and Ki-67 amplification are the most significant predictive factors influencing recurrence rates. The algorithm for assessing the risk of recurrence of stage I breast cancer can predict the risk of tumour progression with a sensitivity of 84 % and a specificity of 58 % (p 0.05).Keywords
This publication has 14 references indexed in Scilit:
- Metabolomics in breast cancer: A decade in reviewCancer Treatment Reviews, 2018
- Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)The Breast, 2018
- Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2018
- Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literatureThe American Journal of Surgery, 2018
- Imputing missing quality of life data as covariate in survival analysis of the International Breast Cancer Study Group Trials VI and VIICommunications in Statistics - Simulation and Computation, 2017
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology, 2015
- Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector MachineJournal of Breast Cancer, 2012
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research, 2008
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast CancerJournal of Clinical Oncology, 2001